Rifaximin - Rajeshwar Prosad Mookerjee
Rifaximin is an oral non-systemic antibiotic, with minimal gastrointestinal absorption and broad-spectrum antibacterial activity covering both grampositive and gramnegative organisms. Rifaximin is currently worldwide used in patients with cirrhosis for preventing recurrent hepatic encephalopathy because its efficacy and safety has been proved by large randomized clinical trials.
אמן על פי ציטוט זה
ערוך טקסט
או פשוט השאר תגובה:
